Flash Therapeutics

Flash Therapeutics develops and produces gene based therapies leveraging its proprietary lentiviral production platform through two business lines: gene transfer delivery biotechnologies design (RNA and DNA). Development and manufacturing support to companies worldwide pursuing lentiviral-based projects from R&D to clinical applications.

Depending on the customers’ application, Flash Therapeutics provides integrative lentiviral particles or LentiFlash®, a new non-integrative lentiviral particle. Both technologies benefit from novel production and purification processes developed and continually optimized since 2005.